As per Bharat Biotech, the facility will tackle scientific challenges such as targeted gene expression, immune system modulation, and long-term cell survival. Work will span from boosting immune responses against cancer to ensuring that therapeutic proteins are safely accepted in patients with genetic diseases like haemophilia.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kEcSD0
via IFTTT
No comments:
Post a Comment